Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.
Authors: lionetti R
Date: May 2019
Scope of interest: infectious/hepatological
Authors: lionetti R
Date: May 2019
Scope of interest: infectious/hepatological
Authors: Abbatecola A.M., Bo M., Barbagallo M., Antonelli Incalzi R., Pilotto A., Bellelli G., Maggi S., Paolisso G
Date: 2014
Scope of interest: RSA, diabetes
Authors: M. Albini, M. Fanella, J. Fattouch, S. Casciato, A. Morano, L.M. Basili, A.T. Giallonardo, C. Di Bonaventura
Date: 2016
Scope of interest: Epilepsy
Authors: Morano A, Cerulli Irelli E, Fanella M, Zuliani L, Giallonardo AT, Di Bonaventura C.
Date: 2021
Scope of interest: Epilepsy/autoimmune diseases of the CNS
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide